Literature DB >> 19222711

Malignancy grading is no better than conventional histopathological grading in small squamous cell carcinoma of tongue and floor of mouth: retrospective study in 128 patients.

M Weijers1, G B Snow, P Dick Bezemer, I van der Waal.   

Abstract

There is an ongoing debate about the predictive value of histopathological parameters in oral cancer. In the past decades, the emphasis was on the possible added value of the so-called malignancy grading system. In a retrospective study on 128 previously untreated patients with a T1 or T2 squamous cell carcinoma of the tongue and the floor of the mouth, the value of the classical Broders' grading system and the malignancy grading system were compared with regard to various outcome measures such as regional metastasis, local recurrence and 5-year survival. The results show that neither of the histological grading systems has a strong predictive value and that none is superior to the other.

Entities:  

Mesh:

Year:  2009        PMID: 19222711     DOI: 10.1111/j.1600-0714.2009.00751.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  6 in total

1.  [Squamous cell carcinoma and potentially malignant disorders of the oral mucosa].

Authors:  J Beck-Mannagetta; G Hutarew
Journal:  Hautarzt       Date:  2009-11       Impact factor: 0.751

2.  Tumor budding and adjacent tissue at the invasive front correlate with delayed neck metastasis in clinical early-stage tongue squamous cell carcinoma.

Authors:  Nobuhiro Yamakawa; Tadaaki Kirita; Masahiro Umeda; Souichi Yanamoto; Yoshihide Ota; Mitsunobu Otsuru; Masaya Okura; Hiroshi Kurita; Shin-Ichi Yamada; Takumi Hasegawa; Tomonao Aikawa; Takahide Komori; Michihiro Ueda
Journal:  J Surg Oncol       Date:  2018-12-12       Impact factor: 3.454

3.  Oral squamous cell carcinoma of tongue: Histological risk assessment. A pilot study.

Authors:  B-C Migueláñez-Medrán; J-J Pozo-Kreilinger; J-L Cebrián-Carretero; M-A Martínez-García; A-F López-Sánchez
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2019-09-01

4.  A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 4 (Biomarkers).

Authors:  Martina A Broglie; Pavel Dulguerov; Guido Henke; Marco Siano; Paul Martin Putora; Christian Simon; Daniel Zwahlen; Gerhard F Huber; Giorgio Ballerini; Lorenza Beffa; Roland Giger; Sacha Rothschild; Sandro V Negri; Olgun Elicin
Journal:  Front Oncol       Date:  2019-10-24       Impact factor: 6.244

5.  Efficacy of Multimodal Therapy in the Survival Outcomes of Advanced-Stage (Stage III-Stage IV) Oral Carcinoma Patients: An Institutional Experience in Asian Indian Population.

Authors:  Amit Dhawan; Prahlad Duggal; Ramandeep Singh Bhullar; Tejinder Kaur; Amneet Sandhu; Kirandeep Kaur
Journal:  J Maxillofac Oral Surg       Date:  2017-04-07

6.  Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer.

Authors:  Alhadi Almangush; Ibrahim O Bello; Harri Keski-Säntti; Laura K Mäkinen; Joonas H Kauppila; Matti Pukkila; Jaana Hagström; Jussi Laranne; Satu Tommola; Outi Nieminen; Ylermi Soini; Veli-Matti Kosma; Petri Koivunen; Reidar Grénman; Ilmo Leivo; Tuula Salo
Journal:  Head Neck       Date:  2013-09-02       Impact factor: 3.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.